IQuity Research Unveils Potential $18 Billion in Health Plan Cost-Savings and Demonstrates Effectiveness of Identifying At-Risk Autoimmune Disease Patients
A new global report from Elsevier Health highlights that many clinicians believe artificial intelligence (AI) has the potential to…
10x Genomics’ pharmaceutical and cell therapy customers can leverage Immunai’s artificial intelligence and machine learning technologies to generate granular…
The following article was written by Blair Childs, Senior Vice President of Public Affairs, and Aisha Pittman, MPH, Vice…